Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2975991000168110 | Oxaliplatin (Apo) (oxaliplatin 200 mg / 40 mL) injection, 40 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2976001000168111 | Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | Is a | Oxaliplatin (Apo) | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | Is a | oxaliplatin 200 mg/40 mL injection, vial | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has unit of use | vial | true | Inferred relationship | Some | 537313761 | |
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has intended active ingredient | oxaliplatin | true | Inferred relationship | Some | 537313760 | |
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has Australian BoSS | oxaliplatin | true | Inferred relationship | Some | 537313760 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has TPUU | True | Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | Inferred relationship | Some | 1 |
| Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | has TPUU | True | Oxaliplatin (Apo) 200 mg/40 mL injection, 40 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR